Courtney Thorne


I take life sciences companies public and then I'm there to help clients navigate the waters of being an SEC reporting company.

+1 617 937 2318

Courtney T. Thorne's practice focuses on the representation of public companies and investment banks in the life sciences industry, with an emphasis on capital raising, public company counseling, foreign private issuer matters and securities law compliance. In addition to a robust US practice, she has substantial expertise advising non-US companies (known as foreign private issuers or FPIs) seeking to access the US capital markets and become a US public company. Over the past five years, Courtney has advised 30+ IPOs and offerings, with an aggregate value of approximately $3.0 billion.

Download full bio


  • Oncorus – $98 Million IPO 

  • Repare Therapeutics - $253 Million IPO 

  • Avedro Sells to Glaukos 

  • Avedro – $70 Million IPO 

  • Autolus – $173 Million IPO 

  • View all


    Exploring neighborhood coffee shops

    Volunteering with the Junior League of Boston



  • Suffolk University Law School
    JD, cum laude, Business Law and Financial Services Concentration, with distinction, 2010

  • The George Washington University
    MPA, 2007

  • The George Washington University
    BA, 2005

Admissions & Credentials


New York


  • Boston Bar Association

  • Healthcare Businesswomen's Association

Rankings & Accolades

    Massachusetts Super Lawyers: Rising Star in Business/Corporate Law and Securities & Corporate Finance
    (2015 – 2020)

    IPO Vital Signs: #1 Law Firm for Technology and Life Sciences IPOs Since 2013

PubCo @ Cooley Blog

Focus on providing dynamic thought leadership and curated content for the public securities arena

View blog


+1 617 937 2318 office
+1 617 937 2400 fax

500 Boylston Street
14th Floor
Boston, MA 02116-3736